[go: up one dir, main page]

FR2986430B1 - Utilisation d'un principe actif issu d'eucheuma cottonii riche en galactanes lineaires pour lutter contre la senescence cellulaire cutanee - Google Patents

Utilisation d'un principe actif issu d'eucheuma cottonii riche en galactanes lineaires pour lutter contre la senescence cellulaire cutanee

Info

Publication number
FR2986430B1
FR2986430B1 FR1251087A FR1251087A FR2986430B1 FR 2986430 B1 FR2986430 B1 FR 2986430B1 FR 1251087 A FR1251087 A FR 1251087A FR 1251087 A FR1251087 A FR 1251087A FR 2986430 B1 FR2986430 B1 FR 2986430B1
Authority
FR
France
Prior art keywords
galactanes
rich
linear
active principle
cell senescence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1251087A
Other languages
English (en)
Other versions
FR2986430A1 (fr
Inventor
Jean Paufique
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe Industrielle Limousine dApplication Biologique SA SILAB
Original Assignee
Societe Industrielle Limousine dApplication Biologique SA SILAB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe Industrielle Limousine dApplication Biologique SA SILAB filed Critical Societe Industrielle Limousine dApplication Biologique SA SILAB
Priority to FR1251087A priority Critical patent/FR2986430B1/fr
Priority to EP13706642.9A priority patent/EP2811974A2/fr
Priority to PCT/FR2013/050251 priority patent/WO2013117859A2/fr
Priority to US14/375,455 priority patent/US9463149B2/en
Publication of FR2986430A1 publication Critical patent/FR2986430A1/fr
Application granted granted Critical
Publication of FR2986430B1 publication Critical patent/FR2986430B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706—Algae
    • A61K8/9717—Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1251087A 2012-02-06 2012-02-06 Utilisation d'un principe actif issu d'eucheuma cottonii riche en galactanes lineaires pour lutter contre la senescence cellulaire cutanee Active FR2986430B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1251087A FR2986430B1 (fr) 2012-02-06 2012-02-06 Utilisation d'un principe actif issu d'eucheuma cottonii riche en galactanes lineaires pour lutter contre la senescence cellulaire cutanee
EP13706642.9A EP2811974A2 (fr) 2012-02-06 2013-02-06 Utilisation d'un principe actif issu d'eucheuma cottonii riche en galactanes lineaires pour lutter contre la senescence cellulaire cutanee
PCT/FR2013/050251 WO2013117859A2 (fr) 2012-02-06 2013-02-06 Utilisation d'un principe actif issu d'eucheuma cottonii riche en galactanes lineaires pour lutter contre la senescence cellulaire cutanee
US14/375,455 US9463149B2 (en) 2012-02-06 2013-02-06 Use of an active principle derived from Eucheuma cottonii and rich in linear galactans for controlling skin cell aging

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1251087A FR2986430B1 (fr) 2012-02-06 2012-02-06 Utilisation d'un principe actif issu d'eucheuma cottonii riche en galactanes lineaires pour lutter contre la senescence cellulaire cutanee

Publications (2)

Publication Number Publication Date
FR2986430A1 FR2986430A1 (fr) 2013-08-09
FR2986430B1 true FR2986430B1 (fr) 2014-03-14

Family

ID=47754831

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1251087A Active FR2986430B1 (fr) 2012-02-06 2012-02-06 Utilisation d'un principe actif issu d'eucheuma cottonii riche en galactanes lineaires pour lutter contre la senescence cellulaire cutanee

Country Status (4)

Country Link
US (1) US9463149B2 (fr)
EP (1) EP2811974A2 (fr)
FR (1) FR2986430B1 (fr)
WO (1) WO2013117859A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3018448B1 (fr) * 2014-03-12 2016-04-15 Soc Ind Limousine D'application Biologique Principe actif obtenu a partir de l'algue hypnea musciformis et utilisations cosmetiques
FR3047173B1 (fr) 2016-01-29 2018-02-09 Societe Industrielle Limousine D'application Biologique Agent cosmetique constitue par des galactomannanes obtenus a partir de caesalpinia spinosa et des galactanes sulfates obtenus a partir de kappaphycus alvarezii
FR3047172B1 (fr) * 2016-01-29 2020-05-08 Societe Industrielle Limousine D'application Biologique Agent cosmetique tenseur et/ou filmogene constitue par des galactomannanes et/ou des galactanes sulfates
CN110205367B (zh) * 2018-02-28 2022-06-21 伽蓝（集团）股份有限公司 一种筛选保护皮肤细胞端粒的活性物的方法
FR3106495B1 (fr) 2020-01-29 2023-12-22 Gelyma Composition cosmétique comprenant des extraits de Kappaphycus alvarezii pour le soin anti-irritations, anti-rougeurs, anti-démangeaisons du cuir chevelu
WO2023191088A1 (fr) * 2022-03-31 2023-10-05 協和ファーマケミカル株式会社 Organocatalyseur d'origine végétale

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443486A (en) * 1980-04-09 1984-04-17 Fmc Corporation Modified extractive of Eucheuma cottonii seaweed and composition containing same
US4543250A (en) * 1983-04-11 1985-09-24 Fmc Corporation Toiletry formulations comprising low molecular weight carrageenan
FR2719846B1 (fr) * 1994-05-13 1996-08-09 Simer Laboratoires Science Mer Oligosaccharides de galactanes sulfates et composition cosmétique ou pharmaceutique à usage topique externe contenant lesdits oligosaccharides de galactanes sulfates.
JP2002193736A (ja) * 2000-12-28 2002-07-10 Katakura Chikkarin Co Ltd 化粧料
US8293285B2 (en) * 2008-03-14 2012-10-23 Cp Kelco U.S., Inc. Carrageenan modified by ion-exchange process

Also Published As

Publication number Publication date
WO2013117859A3 (fr) 2014-03-27
US9463149B2 (en) 2016-10-11
FR2986430A1 (fr) 2013-08-09
US20150025036A1 (en) 2015-01-22
WO2013117859A2 (fr) 2013-08-15
EP2811974A2 (fr) 2014-12-17

Similar Documents

Publication Publication Date Title
EP2526963A4 (fr) Préparation en solution contenant un anticorps stabilisé
EP2871180A4 (fr) Dérivé d'ester d'acide 2-aminonicotinique et bactéricide le contenant comme principe actif
EP2911684A4 (fr) Formes d'il-15r alpha, cellules exprimant des formes d'il-15r alpha, et utilisations thérapeutiques d'il-15r alpha et de complexes il-15/il-15r alpha
EP2714009A4 (fr) Formulation liquide stable d'étanercept
EP2834822A4 (fr) Structure d'électrode poreuse
EP2933867A4 (fr) Electrolyte solide contenant un liquide ionique
FR2986430B1 (fr) Utilisation d'un principe actif issu d'eucheuma cottonii riche en galactanes lineaires pour lutter contre la senescence cellulaire cutanee
EP2637690A4 (fr) FORMULATION LIQUIDE D'ANTICORPS ANTI-TNFalpha HAUTEMENT CONCENTRÉE AMÉLIORÉE
EP2804851A4 (fr) Composés thérapeutiquement actifs et leurs procédés d'utilisation
EP2800743A4 (fr) Composés thérapeutiquement actifs et leurs procédés d'utilisation
EP2875005A4 (fr) N-(3-hétéroarylaryl)-4-arylarylcarboxamides et analogues comme inhibiteurs de la voie hedgehog et leur utilisation
IL240252B (en) Solid substrates for promoting cell and tissue growth
EP2909313A4 (fr) Production de globules rouges et de plaquettes à partir de cellules souches
EP2820702A4 (fr) Construction améliorée d'un accumulateur au plomb-acide
EP2629799A4 (fr) Base topique et compositions contenant un principe actif, et procédés d'amélioration et de traitement de la peau
EP2610218A4 (fr) Structure de graphène contenant de l'azote et liquide de dispersion au phosphore
DK2882290T3 (da) System til at holde liv i og transportere hudbiopsier og anvendelse deraf
PL2704741T3 (pl) Sposoby postępowania z lekami biologicznymi zawierającymi żywe komórki
FR2985426B1 (fr) Nouvelle utilisation de la zerumbone et compositions contenant de la zerumbone
EP2819682A4 (fr) Gels topiques contenant des peptides c-terminaux d'alpha connexine (act)
EP2496083A4 (fr) Formulation contenant de la nicotine
BR112013030644A2 (pt) fosfolipídios contendo ácido(s) nitrocarboxílico(s) da estrutura geral (i), e uso dos mesmos, dispositivo médico e composições biopassivadoras
EP2766501A4 (fr) Amplification d'acide nucléique et son utilisation
EP2822654A4 (fr) Peptide de tropisme oralement actif et pénétrant les cellules et procédés d'utilisation associés
EP2552426A4 (fr) Dispositif d'administration de médicaments intravaginal

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

CA Change of address

Effective date: 20241226

PLFP Fee payment

Year of fee payment: 14